Clinical Trials Unit

Clinical Trials Unit

Exploring New Horizons for Tomorrow's Cures

Pakistan, the sixth most populous country in the world, has a disease burden higher than the average in the South Asia region. This underlines the need to come up with innovative and effective diagnostic, preventive and curative regimens specifically designed for the local population.

Clinical trials are considered a necessity for tomorrow’s cures. University hospitals are fast establishing units to streamline, govern and promote their clinical trial activities. In Pakistan too, major global agencies, independent research units and pharmaceuticals have actively initiated and participated in multi-national, multi-centric clinical trials, particularly as technology has helped bridge communication needs.

So far 44 multidisciplinary clinical studies have commenced at the Aga Khan University and an equal number expected to begin in the coming years.

To cater to the changing needs and global trends, in 2011, the Aga Khan University opened  doors to the Clinical Trials Unit — a state-of-the-art facility that offers a full spectrum of core and supporting administrative services to local researchers as well as global organisations.

University News

​Countdown to 2015: a future of hope for Afghanistan

The first comprehensive assessment of reproductive, maternal, newborn, and child health and survival in Afghanistan over the last decade published in the Lancet Global Health. It’s part of the Countdown to 2015 initiative and represents a collaborative effort of several institutions, including AKU.

President's Message

"In 2011, the University opened the Clinical Trials Unit – a centralised state-of-the-art facility. The Unit has since made its presence felt with its Good Clinical Practice-compliant standards and its spectrum of services..."

Read More

Clinical Trials Unit

Get Microsoft Silverlightclinical-trials.wmv

Dr Hibberd's Message

Get Microsoft Silverlightclinical-trials-validator.wmv

Contact Us

Clinical Trials Unit
Tel:  +92 21 3486 2307
        +92 21 3486 2330